$RSII Reading between the lines, it is all there.
Post# of 106703
(Total Views: 451)
Posted On: 03/07/2017 6:11:44 PM
$RSII Reading between the lines, it is all there.
Some continue to think a Stock is supposed to go up Everyday. Not! Patience to see a plan unfold in the Short Term is not hard... for ME. Seems it is for others on some MB's.
We are vested in Rising BioSciences Inc, A Cannabis Biotech. When investing in any Biotech, you base your buys on the Potential in the future, at the cheapest prices possible, as the ride up can come at any time, and be fast!
RISING BIOSCIENCE IS COMPRISED OF A GROUP OF CHEMIST,PHYSICIANS,PHARMACIST AND VETERAN CANNABIS INDUSTRY PROFESSIONALS THAT JOINED FORCES TO RESEARCH AND DEVELOP CANNABIS BASED MEDICINE UNDER THE STRINGENT GUIDELINES USED IN TODAY'S COMPOUNDING PHARMACIES.
OF NOTE, ONE HAS 30 YEARS EXPERIENCE IN COMPOUNDING AS A PHARMACIST. MANAGEMENT HAS STRATEGIC ALLIANCES TO THE ABOVE!
Cannabis Medicines, are in effect Compound drugs, which by definition are physically composed of multiple ingredients --- Cannabis being just one of the ingredients.
THE BUSINESS OPERATORS HAVE REAL EXPERIENCE AND EXPERTISE IN MULTIPLE STATES AND SEVERAL BUSINESS VERTICALS WITHIN THE CANNABIS INDUSTRY. THEY HAVE THE KNOWLEDGE AND KNOW HOW, WITH MANY TIES WITHIN THE ALTERNATIVE MEDICAL AND CANNABIS PHARMACEUTICAL MARKETS.
AS ROBERT HAS STATED, THERE ARE A NUMBER OF OPPORTUNITIES IN DEVELOPMENT AND MARKETING OF CANNABIS PHARMACEUTICALS THAT ARE SYNERGISTIC WITH PAO GROUP AND BEYOND.
RISING BIOSCIENCE IS FOCUSING ON ORAL AND TOPICAL PHARMACEUTICALS. Aside from cancer treatment and pain management, some of the uses for medical marijuana include treatment of conditions such as seizure disorders, multiple sclerosis, Parkinson's disease, rheumatoid arthritis, glaucoma and Crohn's disease.
Operations will focus on creating product that can be metabolized by the body more efficiently, and with delivery methods more acceptable than smoking, tinctures and oils available on the market today.
Procedures will include consistency in terms of quality and true dosage measures of CBD and/or THC delivery through each product the company develops and manufactures.
Rising BioSciences seeks to fulfill a yet-to-be-met market demand with a first to market approach so that patients across the U.S. get the treatment they so desperately need without falling subject to the dangers of opiates, whose long-term effects can include liver damage, dependence/addiction and brain damage due to hypoxia, resulting from respiratory depression, among other complications."
AS NOTED, WE IN IN THE FINAL STAGES OF THE MERGER BEING COMPLETED. NO RS, NO RAISING SHARES TO GET THIS DEAL DONE. THERE IS NO DILUTION, JUST PANIC STRICKEN VESTORS AND SHORTS. NOTICE HOW EASY IT MOVES. IMO, OPERATIONS ARE UP AND RUNNING. MERGER WILL GET DONE, NEW TICKER WILL BE NEXT AND THE STOCK WILL BE EXPLODING NORTH WHEN LEARNING OF WHO MANAGEMENT IS, AS WELL AS THERE TIES TO THE INDUSTRY.
RISING IS SEPARATE FROM $NWAV, PAO GROUP FOLKS. THERE ARE SYNERGIES BETWEEN THE TWO, AS RISING WILL BE SUPPLYING PAO CLINICS EVERYWHERE. BUT, WILL ALSO BE SERVING NATIONWIDE AND WILL HAVE THE CHANCE FOR MONSTER GROWTH!!
THE POTENTIAL IS ENORMOUS FOR THIS BIOTECH IMO! I KNOW WHAT I OWN, WILL NOT GIVE AWAY MY SHARES, AND LOOK FORWARD TO SEEING THIS COMPANY GROW, FASTER THAN MANY REALIZE!
MY LAST DD POST FOLKS, I WILL SIT BACK AND WATCH IT ALL UNFOLD!
Some continue to think a Stock is supposed to go up Everyday. Not! Patience to see a plan unfold in the Short Term is not hard... for ME. Seems it is for others on some MB's.
We are vested in Rising BioSciences Inc, A Cannabis Biotech. When investing in any Biotech, you base your buys on the Potential in the future, at the cheapest prices possible, as the ride up can come at any time, and be fast!
RISING BIOSCIENCE IS COMPRISED OF A GROUP OF CHEMIST,PHYSICIANS,PHARMACIST AND VETERAN CANNABIS INDUSTRY PROFESSIONALS THAT JOINED FORCES TO RESEARCH AND DEVELOP CANNABIS BASED MEDICINE UNDER THE STRINGENT GUIDELINES USED IN TODAY'S COMPOUNDING PHARMACIES.
OF NOTE, ONE HAS 30 YEARS EXPERIENCE IN COMPOUNDING AS A PHARMACIST. MANAGEMENT HAS STRATEGIC ALLIANCES TO THE ABOVE!
Cannabis Medicines, are in effect Compound drugs, which by definition are physically composed of multiple ingredients --- Cannabis being just one of the ingredients.
THE BUSINESS OPERATORS HAVE REAL EXPERIENCE AND EXPERTISE IN MULTIPLE STATES AND SEVERAL BUSINESS VERTICALS WITHIN THE CANNABIS INDUSTRY. THEY HAVE THE KNOWLEDGE AND KNOW HOW, WITH MANY TIES WITHIN THE ALTERNATIVE MEDICAL AND CANNABIS PHARMACEUTICAL MARKETS.
AS ROBERT HAS STATED, THERE ARE A NUMBER OF OPPORTUNITIES IN DEVELOPMENT AND MARKETING OF CANNABIS PHARMACEUTICALS THAT ARE SYNERGISTIC WITH PAO GROUP AND BEYOND.
RISING BIOSCIENCE IS FOCUSING ON ORAL AND TOPICAL PHARMACEUTICALS. Aside from cancer treatment and pain management, some of the uses for medical marijuana include treatment of conditions such as seizure disorders, multiple sclerosis, Parkinson's disease, rheumatoid arthritis, glaucoma and Crohn's disease.
Operations will focus on creating product that can be metabolized by the body more efficiently, and with delivery methods more acceptable than smoking, tinctures and oils available on the market today.
Procedures will include consistency in terms of quality and true dosage measures of CBD and/or THC delivery through each product the company develops and manufactures.
Rising BioSciences seeks to fulfill a yet-to-be-met market demand with a first to market approach so that patients across the U.S. get the treatment they so desperately need without falling subject to the dangers of opiates, whose long-term effects can include liver damage, dependence/addiction and brain damage due to hypoxia, resulting from respiratory depression, among other complications."
AS NOTED, WE IN IN THE FINAL STAGES OF THE MERGER BEING COMPLETED. NO RS, NO RAISING SHARES TO GET THIS DEAL DONE. THERE IS NO DILUTION, JUST PANIC STRICKEN VESTORS AND SHORTS. NOTICE HOW EASY IT MOVES. IMO, OPERATIONS ARE UP AND RUNNING. MERGER WILL GET DONE, NEW TICKER WILL BE NEXT AND THE STOCK WILL BE EXPLODING NORTH WHEN LEARNING OF WHO MANAGEMENT IS, AS WELL AS THERE TIES TO THE INDUSTRY.
RISING IS SEPARATE FROM $NWAV, PAO GROUP FOLKS. THERE ARE SYNERGIES BETWEEN THE TWO, AS RISING WILL BE SUPPLYING PAO CLINICS EVERYWHERE. BUT, WILL ALSO BE SERVING NATIONWIDE AND WILL HAVE THE CHANCE FOR MONSTER GROWTH!!
THE POTENTIAL IS ENORMOUS FOR THIS BIOTECH IMO! I KNOW WHAT I OWN, WILL NOT GIVE AWAY MY SHARES, AND LOOK FORWARD TO SEEING THIS COMPANY GROW, FASTER THAN MANY REALIZE!
MY LAST DD POST FOLKS, I WILL SIT BACK AND WATCH IT ALL UNFOLD!
(1)
(1)